Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 171 entries
Sorted by: Best Match Show Resources per page
[Orientation at the time of hospital admission. 2. Orientation of patients to ease their anxiety].

Kangogaku zasshi

Kamimura M, Ishinabe K, Katada M, Kinoshita Y, Kuwano T.
PMID: 4995178
Kangogaku Zasshi. 1971 Apr;35(4):15-8.

No abstract available.

Cite
Kamimura M, Ishinabe K, Katada M, et al. [Orientation at the time of hospital admission. 2. Orientation of patients to ease their anxiety]. Kangogaku Zasshi. 1971;35(4):15-8
Kamimura, M., Ishinabe, K., Katada, M., Kinoshita, Y., & Kuwano, T. (1971). [Orientation at the time of hospital admission. 2. Orientation of patients to ease their anxiety]. Kangogaku zasshi, 35(4), 15-8.
Kamimura, M, et al. "[Orientation at the time of hospital admission. 2. Orientation of patients to ease their anxiety]." Kangogaku zasshi vol. 35,4 (1971): 15-8.
Kamimura M, Ishinabe K, Katada M, Kinoshita Y, Kuwano T. [Orientation at the time of hospital admission. 2. Orientation of patients to ease their anxiety]. Kangogaku Zasshi. 1971 Apr;35(4):15-8. Japanese. PMID: 4995178.
Copy Download .nbib Format: NLM
[Conceptual framework of the curriculum in nursing education. 1].

[Kango kyoiku] Japanese journal of nurses' education

Nakai T, Yamazaki K, Mori Y, Ishinabe K, Kamigaki T.
PMID: 251688
Kango Kyoiku. 1978 Nov;19(11):661-2.

No abstract available.

Cite
Nakai T, Yamazaki K, Mori Y, et al. [Conceptual framework of the curriculum in nursing education. 1]. Kango Kyoiku. 1978;19(11):661-2
Nakai, T., Yamazaki, K., Mori, Y., Ishinabe, K., & Kamigaki, T. (1978). [Conceptual framework of the curriculum in nursing education. 1]. [Kango kyoiku] Japanese journal of nurses' education, 19(11), 661-2.
Nakai, T, et al. "[Conceptual framework of the curriculum in nursing education. 1]." [Kango kyoiku] Japanese journal of nurses' education vol. 19,11 (1978): 661-2.
Nakai T, Yamazaki K, Mori Y, Ishinabe K, Kamigaki T. [Conceptual framework of the curriculum in nursing education. 1]. Kango Kyoiku. 1978 Nov;19(11):661-2. Japanese. PMID: 251688.
Copy Download .nbib Format: NLM
Successful hepatectomy for hepatic abscess with chronic granulomatous disease: a case report.

Surgical case reports

Muranushi R, Suzuki M, Araki K, Kubo N, Otake S, Nishida Y, Ishige T, Arakawa H, Kuwano H, Shirabe K.
PMID: 28447322
Surg Case Rep. 2017 Dec;3(1):57. doi: 10.1186/s40792-017-0333-z. Epub 2017 Apr 26.

BACKGROUND: Chronic granulomatous disease (CGD), a rare inherited disorder, is characterized by impaired ability of phagocytic cells to kill certain bacteria and fungi. Although liver abscess is a common manifestation of CGD, its optimal management in these patients is...

Cite
Muranushi R, Suzuki M, Araki K, et al. Successful hepatectomy for hepatic abscess with chronic granulomatous disease: a case report. Surg Case Rep. 2017;3(1):57doi: 10.1186/s40792-017-0333-z.
Muranushi, R., Suzuki, M., Araki, K., Kubo, N., Otake, S., Nishida, Y., Ishige, T., Arakawa, H., Kuwano, H., & Shirabe, K. (2017). Successful hepatectomy for hepatic abscess with chronic granulomatous disease: a case report. Surgical case reports, 3(1), 57. https://doi.org/10.1186/s40792-017-0333-z
Muranushi, Ryo, et al. "Successful hepatectomy for hepatic abscess with chronic granulomatous disease: a case report." Surgical case reports vol. 3,1 (2017): 57. doi: https://doi.org/10.1186/s40792-017-0333-z
Muranushi R, Suzuki M, Araki K, Kubo N, Otake S, Nishida Y, Ishige T, Arakawa H, Kuwano H, Shirabe K. Successful hepatectomy for hepatic abscess with chronic granulomatous disease: a case report. Surg Case Rep. 2017 Dec;3(1):57. doi: 10.1186/s40792-017-0333-z. Epub 2017 Apr 26. PMID: 28447322; PMCID: PMC5406309.
Copy Download .nbib Format: NLM
Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma.

Hepatology research : the official journal of the Japan Society of Hepatology

Itoh S, Yoshizumi T, Shirabe K, Kimura K, Okabe H, Harimoto N, Ikegami T, Uchiyama H, Nishie A, Maehara Y.
PMID: 27283504
Hepatol Res. 2017 Apr;47(5):398-404. doi: 10.1111/hepr.12761. Epub 2016 Sep 12.

AIM: We aimed to evaluate whether functional assessment of the future remnant liver is a predictor of postoperative morbidity after hepatic resection in patients with hepatocellular carcinoma (HCC).METHODS: One hundred forty-six patients who underwent hepatic resection for HCC were...

Cite
Itoh S, Yoshizumi T, Shirabe K, et al. Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma. Hepatol Res. 2016;47(5):398-404doi: 10.1111/hepr.12761.
Itoh, S., Yoshizumi, T., Shirabe, K., Kimura, K., Okabe, H., Harimoto, N., Ikegami, T., Uchiyama, H., Nishie, A., & Maehara, Y. (2017). Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology, 47(5), 398-404. https://doi.org/10.1111/hepr.12761
Itoh, Shinji, et al. "Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma." Hepatology research : the official journal of the Japan Society of Hepatology vol. 47,5 (2017): 398-404. doi: https://doi.org/10.1111/hepr.12761
Itoh S, Yoshizumi T, Shirabe K, Kimura K, Okabe H, Harimoto N, Ikegami T, Uchiyama H, Nishie A, Maehara Y. Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma. Hepatol Res. 2017 Apr;47(5):398-404. doi: 10.1111/hepr.12761. Epub 2016 Sep 12. PMID: 27283504.
Copy Download .nbib Format: NLM
Sarcopenia is a predictive factor for prolonged intensive care unit stays in high-energy blunt trauma patients.

Acute medicine & surgery

Akahoshi T, Yasuda M, Momii K, Kubota K, Shono Y, Kaku N, Tokuda K, Nagata T, Yoshizumi T, Shirabe K, Hashizume M, Maehara Y.
PMID: 29123807
Acute Med Surg. 2016 May 02;3(4):326-331. doi: 10.1002/ams2.195. eCollection 2016 Oct.

AIM: Sarcopenia has been increasingly reported as a prognostic factor for outcome in settings such as cirrhosis, liver transplantation, and emergent surgery. We aimed to elucidate the significance of sarcopenia in severe blunt trauma patients.METHODS: We retrospectively analyzed 84...

Cite
Akahoshi T, Yasuda M, Momii K, et al. Sarcopenia is a predictive factor for prolonged intensive care unit stays in high-energy blunt trauma patients. Acute Med Surg. 2016;3(4):326-331doi: 10.1002/ams2.195.
Akahoshi, T., Yasuda, M., Momii, K., Kubota, K., Shono, Y., Kaku, N., Tokuda, K., Nagata, T., Yoshizumi, T., Shirabe, K., Hashizume, M., & Maehara, Y. (2016). Sarcopenia is a predictive factor for prolonged intensive care unit stays in high-energy blunt trauma patients. Acute medicine & surgery, 3(4), 326-331. https://doi.org/10.1002/ams2.195
Akahoshi, Tomohiko, et al. "Sarcopenia is a predictive factor for prolonged intensive care unit stays in high-energy blunt trauma patients." Acute medicine & surgery vol. 3,4 (2016): 326-331. doi: https://doi.org/10.1002/ams2.195
Akahoshi T, Yasuda M, Momii K, Kubota K, Shono Y, Kaku N, Tokuda K, Nagata T, Yoshizumi T, Shirabe K, Hashizume M, Maehara Y. Sarcopenia is a predictive factor for prolonged intensive care unit stays in high-energy blunt trauma patients. Acute Med Surg. 2016 May 02;3(4):326-331. doi: 10.1002/ams2.195. eCollection 2016 Oct. PMID: 29123807; PMCID: PMC5667315.
Copy Download .nbib Format: NLM
Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: Special reference to sarcopenia and postoperative early nutrition.

Hepatology research : the official journal of the Japan Society of Hepatology

Toshima T, Shirabe K, Kurihara T, Itoh S, Harimoto N, Ikegami T, Yoshizumi T, Kawanaka H, Ikeda T, Maehara Y.
PMID: 25586674
Hepatol Res. 2015 Dec;45(12):1170-7. doi: 10.1111/hepr.12484. Epub 2015 Mar 03.

AIM: Sarcopenia is an independent predictor of mortality and sepsis after living donor liver transplantation (LDLT). However, the exact mechanisms by which sarcopenia affects poor prognosis or worse immunity against postoperative sepsis are unclear, particularly regarding muscular amino acid...

Cite
Toshima T, Shirabe K, Kurihara T, et al. Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: Special reference to sarcopenia and postoperative early nutrition. Hepatol Res. 2015;45(12):1170-7doi: 10.1111/hepr.12484.
Toshima, T., Shirabe, K., Kurihara, T., Itoh, S., Harimoto, N., Ikegami, T., Yoshizumi, T., Kawanaka, H., Ikeda, T., & Maehara, Y. (2015). Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: Special reference to sarcopenia and postoperative early nutrition. Hepatology research : the official journal of the Japan Society of Hepatology, 45(12), 1170-7. https://doi.org/10.1111/hepr.12484
Toshima, Takeo, et al. "Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: Special reference to sarcopenia and postoperative early nutrition." Hepatology research : the official journal of the Japan Society of Hepatology vol. 45,12 (2015): 1170-7. doi: https://doi.org/10.1111/hepr.12484
Toshima T, Shirabe K, Kurihara T, Itoh S, Harimoto N, Ikegami T, Yoshizumi T, Kawanaka H, Ikeda T, Maehara Y. Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: Special reference to sarcopenia and postoperative early nutrition. Hepatol Res. 2015 Dec;45(12):1170-7. doi: 10.1111/hepr.12484. Epub 2015 Mar 03. PMID: 25586674.
Copy Download .nbib Format: NLM
Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures.

Translational gastroenterology and hepatology

Uchiyama H, Shirabe K, Araki K, Sugimachi K, Morita K, Takenaka K, Maehara Y.
PMID: 28529988
Transl Gastroenterol Hepatol. 2017 Apr 28;2:34. doi: 10.21037/tgh.2017.03.16. eCollection 2017.

Hepatectomy needing simultaneous reconstruction of the hepatic artery and the portal vein in the operation for cholangiocarcinoma is a challenging procedure. We experienced three cases of left hepatectomy with simultaneous reconstructions of the right hepatic artery (RHA) and the...

Cite
Uchiyama H, Shirabe K, Araki K, et al. Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures. Transl Gastroenterol Hepatol. 2017;2:34doi: 10.21037/tgh.2017.03.16.
Uchiyama, H., Shirabe, K., Araki, K., Sugimachi, K., Morita, K., Takenaka, K., & Maehara, Y. (2017). Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures. Translational gastroenterology and hepatology, 234. https://doi.org/10.21037/tgh.2017.03.16
Uchiyama, Hideaki, et al. "Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures." Translational gastroenterology and hepatology vol. 2 (2017): 34. doi: https://doi.org/10.21037/tgh.2017.03.16
Uchiyama H, Shirabe K, Araki K, Sugimachi K, Morita K, Takenaka K, Maehara Y. Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures. Transl Gastroenterol Hepatol. 2017 Apr 28;2:34. doi: 10.21037/tgh.2017.03.16. eCollection 2017. PMID: 28529988; PMCID: PMC5420523.
Copy Download .nbib Format: NLM
Activation of Stellate Cells Before Induction of Hepatic Fibrosis - Precise Timing in Choline-deficient Diet-fed Rat Model.

Comparative hepatology

Besshi K, Fujiwara M, Senoo H, Kondou Y, Ohsugi Y, Hayashi T, Ishidate K.
PMID: 14960166
Comp Hepatol. 2004 Jan 14;3:S14. doi: 10.1186/1476-5926-2-S1-S14.

No abstract available.

Cite
Besshi K, Fujiwara M, Senoo H, et al. Activation of Stellate Cells Before Induction of Hepatic Fibrosis - Precise Timing in Choline-deficient Diet-fed Rat Model. Comp Hepatol. 2004;3:S14doi: 10.1186/1476-5926-2-S1-S14.
Besshi, K., Fujiwara, M., Senoo, H., Kondou, Y., Ohsugi, Y., Hayashi, T., & Ishidate, K. (2004). Activation of Stellate Cells Before Induction of Hepatic Fibrosis - Precise Timing in Choline-deficient Diet-fed Rat Model. Comparative hepatology, 3S14. https://doi.org/10.1186/1476-5926-2-S1-S14
Besshi, Kazuhiko, et al. "Activation of Stellate Cells Before Induction of Hepatic Fibrosis - Precise Timing in Choline-deficient Diet-fed Rat Model." Comparative hepatology vol. 3 (2004): S14. doi: https://doi.org/10.1186/1476-5926-2-S1-S14
Besshi K, Fujiwara M, Senoo H, Kondou Y, Ohsugi Y, Hayashi T, Ishidate K. Activation of Stellate Cells Before Induction of Hepatic Fibrosis - Precise Timing in Choline-deficient Diet-fed Rat Model. Comp Hepatol. 2004 Jan 14;3:S14. doi: 10.1186/1476-5926-2-S1-S14. PMID: 14960166; PMCID: PMC2410237.
Copy Download .nbib Format: NLM
Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions.

Cytotechnology

Nakazawa K, Mizumoto H, Kaneko M, Ijima H, Gion T, Shimada M, Shirabe K, Takenaka K, Sugimachi K, Funatsu K.
PMID: 19003125
Cytotechnology. 1999 Sep;31(1):61-8. doi: 10.1023/A:1008040726236.

Porcine hepatocytes are used in the hybrid artificial liver support system that we are developing because of their high level of liver functions in vitro and because human hepatocytes can not be used in Japan for ethical reasons. Spherical...

Cite
Nakazawa K, Mizumoto H, Kaneko M, et al. Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions. Cytotechnology. 1999;31(1):61-8doi: 10.1023/A:1008040726236.
Nakazawa, K., Mizumoto, H., Kaneko, M., Ijima, H., Gion, T., Shimada, M., Shirabe, K., Takenaka, K., Sugimachi, K., & Funatsu, K. (1999). Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions. Cytotechnology, 31(1), 61-8. https://doi.org/10.1023/A:1008040726236
Nakazawa, K, et al. "Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions." Cytotechnology vol. 31,1 (1999): 61-8. doi: https://doi.org/10.1023/A:1008040726236
Nakazawa K, Mizumoto H, Kaneko M, Ijima H, Gion T, Shimada M, Shirabe K, Takenaka K, Sugimachi K, Funatsu K. Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions. Cytotechnology. 1999 Sep;31(1):61-8. doi: 10.1023/A:1008040726236. PMID: 19003125; PMCID: PMC3449777.
Copy Download .nbib Format: NLM
Intrahepatic bile duct recurrence of hepatocellular carcinoma without a detectable liver tumor.

International journal of surgery case reports

Abe T, Kajiyama K, Harimoto N, Gion T, Shirabe K, Nagaie T.
PMID: 22516418
Int J Surg Case Rep. 2012;3(7):275-8. doi: 10.1016/j.ijscr.2012.03.017. Epub 2012 Mar 28.

INTRODUCTION: Invasion of the portal and hepatic veins by hepatocellular carcinoma (HCC) is common, but macroscopic bile duct invasion is rare. Once a tumor thrombus completely obstructs the main bile duct, it causes obstructive jaundice. This type of HCC,...

Cite
Abe T, Kajiyama K, Harimoto N, et al. Intrahepatic bile duct recurrence of hepatocellular carcinoma without a detectable liver tumor. Int J Surg Case Rep. 2012;3(7):275-8doi: 10.1016/j.ijscr.2012.03.017.
Abe, T., Kajiyama, K., Harimoto, N., Gion, T., Shirabe, K., & Nagaie, T. (2012). Intrahepatic bile duct recurrence of hepatocellular carcinoma without a detectable liver tumor. International journal of surgery case reports, 3(7), 275-8. https://doi.org/10.1016/j.ijscr.2012.03.017
Abe, Tomoyuki, et al. "Intrahepatic bile duct recurrence of hepatocellular carcinoma without a detectable liver tumor." International journal of surgery case reports vol. 3,7 (2012): 275-8. doi: https://doi.org/10.1016/j.ijscr.2012.03.017
Abe T, Kajiyama K, Harimoto N, Gion T, Shirabe K, Nagaie T. Intrahepatic bile duct recurrence of hepatocellular carcinoma without a detectable liver tumor. Int J Surg Case Rep. 2012;3(7):275-8. doi: 10.1016/j.ijscr.2012.03.017. Epub 2012 Mar 28. PMID: 22516418; PMCID: PMC3356541.
Copy Download .nbib Format: NLM
Global standardization of laparoscopic liver resection and challenges for the future.

Hepatobiliary surgery and nutrition

Araki K, Harimoto N, Shirabe K.
PMID: 31489309
Hepatobiliary Surg Nutr. 2019 Aug;8(4):386-388. doi: 10.21037/hbsn.2019.02.08.

No abstract available.

Cite
Araki K, Harimoto N, Shirabe K. Global standardization of laparoscopic liver resection and challenges for the future. Hepatobiliary Surg Nutr. 2019;8(4):386-388doi: 10.21037/hbsn.2019.02.08.
Araki, K., Harimoto, N., & Shirabe, K. (2019). Global standardization of laparoscopic liver resection and challenges for the future. Hepatobiliary surgery and nutrition, 8(4), 386-388. https://doi.org/10.21037/hbsn.2019.02.08
Araki, Kenichiro, et al. "Global standardization of laparoscopic liver resection and challenges for the future." Hepatobiliary surgery and nutrition vol. 8,4 (2019): 386-388. doi: https://doi.org/10.21037/hbsn.2019.02.08
Araki K, Harimoto N, Shirabe K. Global standardization of laparoscopic liver resection and challenges for the future. Hepatobiliary Surg Nutr. 2019 Aug;8(4):386-388. doi: 10.21037/hbsn.2019.02.08. PMID: 31489309; PMCID: PMC6700003.
Copy Download .nbib Format: NLM
Corrigendum to "A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger" [Radiother. Oncol. 132 (2019) 230-235].

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Shibuya K, Ohno T, Katoh H, Okamoto M, Shiba S, Koyama Y, Kakizaki S, Shirabe K, Nakano T.
PMID: 32008869
Radiother Oncol. 2020 Feb;143:126-127. doi: 10.1016/j.radonc.2019.12.003. Epub 2020 Jan 30.

No abstract available.

Cite
Shibuya K, Ohno T, Katoh H, et al. Corrigendum to "A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger" [Radiother. Oncol. 132 (2019) 230-235]. Radiother Oncol. 2020;143:126-127doi: 10.1016/j.radonc.2019.12.003.
Shibuya, K., Ohno, T., Katoh, H., Okamoto, M., Shiba, S., Koyama, Y., Kakizaki, S., Shirabe, K., & Nakano, T. (2020). Corrigendum to "A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger" [Radiother. Oncol. 132 (2019) 230-235]. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 143126-127. https://doi.org/10.1016/j.radonc.2019.12.003
Shibuya, Kei, et al. "Corrigendum to "A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger" [Radiother. Oncol. 132 (2019) 230-235]." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 143 (2020): 126-127. doi: https://doi.org/10.1016/j.radonc.2019.12.003
Shibuya K, Ohno T, Katoh H, Okamoto M, Shiba S, Koyama Y, Kakizaki S, Shirabe K, Nakano T. Corrigendum to "A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger" [Radiother. Oncol. 132 (2019) 230-235]. Radiother Oncol. 2020 Feb;143:126-127. doi: 10.1016/j.radonc.2019.12.003. Epub 2020 Jan 30. PMID: 32008869.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 171 entries